NCT06084884: An ongoing trial by AstraZeneca
This trial is ongoing. It must report results 2 years, 12 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06084884 |
|---|---|
| Title | A Phase I/II Open-Label Study to Evaluate the Safety, Cellular Kinetics and Efficacy of AZD5851, a Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Directed Against GPC3 in Adult Participants With Advanced/Recurrent Hepatocellular Carcinoma: ATHENA |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 14, 2023 |
| Completion date | Dec. 13, 2027 |
| Required reporting date | Dec. 12, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |